Effects of dihydropyridines on cerebral blood vessels.

To evaluate the effects of dihydropyridine calcium antagonists on the cerebral circulation in stroke patients. DESIGN OF STUDIES: Mean cerebral circulation parameters were studied in chronic stroke patients with hypertension and treated acutely or chronically (2 weeks) with nicardipine or nifedipine retard. The effects of nicardipine on local cerebral blood flow were also studied in patients with a subacute brain infarction.
Mean cerebral blood flow was significantly increased after a single oral administration of nicardipine but not after nifedipine retard. Both calcium antagonists reduced mean arterial pressure. Nifedipine retard acted mainly by reducing blood pressure and nicardipine mainly by reducing cerebrovascular resistance.
Dihydropyridines have a beneficial effect in the control of hypertension in stroke patients.
AuthorsY Kuriyama, H Hashimoto, K Nagatsuka, T Sawada, T Omae
JournalJournal of hypertension. Supplement : official journal of the International Society of Hypertension (J Hypertens Suppl) Vol. 11 Issue 6 Pg. S9-12 (Dec 1993) ISSN: 0952-1178 [Print] ENGLAND
PMID8169383 (Publication Type: Journal Article)
Chemical References
  • Nicardipine
  • Nifedipine
  • Administration, Oral
  • Blood Pressure (drug effects)
  • Cerebral Infarction (complications, drug therapy, physiopathology)
  • Cerebrovascular Circulation (drug effects)
  • Cerebrovascular Disorders (complications, drug therapy, physiopathology)
  • Female
  • Humans
  • Hypertension (complications, drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Nicardipine (administration & dosage, blood, pharmacology)
  • Nifedipine (administration & dosage, blood, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: